Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels Continue Reading »
Share diaTribe by making a gift of $25 today!
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels Continue Reading »
Control-IQ the first AID system with automatic correction boluses and no fingersticks CGM (Dexcom G6); cleared for those ages 14 and older; launch in January 2020 Continue Reading »
A new paper suggests that as people with diabetes increase their time in range, healthcare costs decrease Continue Reading »
As we demand more nutritious and sustainable food, big food companies must make adjustments to their products, practices, and marketing Continue Reading »
Will the medication move from “off label” to standard of care for people at high risk of developing type 2 diabetes? Continue Reading »
The diaTribe team was in Barcelona for the 55th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the conference! Continue Reading »
A collaboration between JDRF, Stanford, and UCSF aims to cure type 1 diabetes through understanding of stem cells and the immune system Continue Reading »
